← Scroll for more →
Arrowhead Pharmaceuticals, Inc. (ARWR)
Pharmaceutical Preparations
Latest Price
$60.49
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
3.31
P/B Ratio
18.30
Valuation metrics
adjust assumptions →Base FCF: $152M (median of recent 5yr)
Growth: 5%/yr (median YOY, capped at 25%)
Discount rate: 10%
Terminal growth: 3%
Projection horizon: 10 years
DCF Fair Value
$20.80
65% downside
Institutional Ownership
85.1% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 14.83M | $1.21B | 10.51% | -3.33M | 2026-06-30 |
| Avoro Capital Advisors LLC | 11.36M | $925.0M | 8.05% | +655.6K | 2026-06-30 |
| FMR LLC | 8.04M | $655.0M | 5.70% | +773.2K | 2026-06-30 |
| Vanguard Portfolio Management LLC | 6.35M | $517.0M | 4.50% | -794.8K | 2026-06-30 |
| Vanguard Capital Management LLC | 6.11M | $498.0M | 4.33% | +78.5K | 2026-06-30 |
| State Street Corp | 5.69M | $464.0M | 4.03% | -801.5K | 2026-06-30 |
| Norges Bank | 3.90M | $317.0M | 2.76% | +2.19M | 2026-06-30 |
| Invesco Ltd. | 3.88M | $316.0M | 2.75% | +603.3K | 2026-06-30 |
| Geode Capital Management, LLC | 3.53M | $298.0M | 2.50% | -748.2K | 2026-06-30 |
| Fred Alger Management, LLC | 3.30M | $269.0M | 2.34% | -40.6K | 2026-06-30 |